MOLCURE Inc. has announced a multiyear strategic research agreement with Boehringer Ingelheim to discover innovative antibody therapeutics for multiple targets using the Japanese company’s proprietary artificial intelligence platform technology. The collaboration will combine MOLCURE’s AI-driven platform with Boehringer Ingelheim’s expertise in biologics development, aiming to expand the scope and efficiency of antibody drug discovery beyond […]

Cambridge-based Owlstone Medical has been awarded up to US$49.1 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop a multi-cancer early detection test that can be performed at home using breath and urine samples. The funding forms part of ARPA-H’s Platform Optimising SynBio for Early Intervention and Detection in Oncology (POSEIDON) programme, […]

Neogap Therapeutics AB has been granted Chinese patent protecting its proprietary method for expanding tumour-specific T cells, marking a significant milestone in the company’s international intellectual property strategy. The patent, which provides legal protection until 2038, covers a core manufacturing process for the company’s personalised cell-based immunotherapy, pTTL, currently under evaluation in Phase I/II clinical […]

Nabsys 2.0, LLC presented data on its OhmX™ Platform at the American Society of Human Genetics (ASHG) Annual Meeting in Boston, Massachusetts, from 14-18 October 2025. The presentations demonstrated applications of electronic genome mapping (EGM) technology in multiple disease states, including interstitial cystitis/bladder pain syndrome, hematological malignancies, and repeat expansion disorders.

Celonic Group, a biologics contract development and manufacturing organisation based in Basel, Switzerland, has entered into a strategic alliance with CARBOGEN AMCIS to establish an end-to-end platform for antibody-drug conjugate (ADC) production. The collaboration combines Celonic’s upstream biologics capabilities with CARBOGEN AMCIS’s downstream expertise in payload synthesis, conjugation chemistry, and sterile fill-finish operations.